Healionics Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Series A1
  • Latest Deal Amount
  • $4.7M
Latest Deal Amount
  • Investors
  • 17

Healionics General Information

Description

Developer of synthetic biomaterial-based vascular graft designed to improve dialysis access in patients with kidney failure. The company's vascular graft resists the problems of occlusion and infection suffered by current devices, enabling medical practitioners to treat kidney patients who undergo dialysis treatment in a better and safe manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Primary Office
  • 2121 North 35th Street
  • Suite 200
  • Seattle, WA 98103
  • United States
+1 (206) 000-0000

Healionics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Healionics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Early Stage VC (Series A1) 06-Apr-2021 $4.7M 000.00 000.00 Completed Clinical Trials - General
14. Later Stage VC 01-Jan-2021 000.00 000.00 Completed Clinical Trials - General
13. Debt - PPP 27-Apr-2020 00000 000.00 Completed Clinical Trials - General
12. Debt - General 24-Sep-2019 00.00 000.00 Completed Clinical Trials - General
11. Early Stage VC 31-Jul-2019 00000 00.000 Completed Clinical Trials - General
10. Later Stage VC 01-Dec-2018 00.000 00.000 Completed Clinical Trials - General
9. Grant 16-Nov-2017 00.00 00.000 Completed Clinical Trials - General
8. Grant 01-Dec-2015 00.00 00.000 Completed Clinical Trials - General
7. Grant 08-Sep-2014 $224K $4.64M Completed Clinical Trials - General
6. Grant 20-Sep-2012 $900K $4.64M Completed Startup
To view Healionics’s complete valuation and funding history, request access »

Healionics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 0,000,000 00.000000 00.00 00.00 00.00 00.00 00.000
Series A-2 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00
Seed-III 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Seed-II 320,000 $0.001000 $1.01 $12.66 $12.66 1x $9.25 6.34%
Seed-I 300,000 $0.001000 $0.47 $5.91 $5.91 1x $5.01 5.12%
To view Healionics’s complete cap table history, request access »

Healionics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of synthetic biomaterial-based vascular graft designed to improve dialysis access in patients with kidney fail
Therapeutic Devices
Seattle, WA
10 As of 2020
000.00
00.00 0000-00-00
00000000000 000.00

00000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
00000000000 0000000
Tampa, FL
000.00
000000000000 000.00

0000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dol
0000000000 000000000
Burnaby, Canada
000 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Healionics Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Keystone Heart Private Equity-Backed Tampa, FL 000.00 000000000000 000.00
0000000 Venture Capital-Backed Burnaby, Canada 000 00000 0000000000 0 00000
00000000 000000000 Venture Capital-Backed Emeryville, CA 00 00000 00000000000 00000
000000000 Corporate Backed or Acquired Berlin, Germany 0000 000000&0
000000 0000000 Venture Capital-Backed Wayne, PA 00 000.00 00000000000 000.00
You’re viewing 5 of 40 competitors. Get the full list »

Healionics Patents

Healionics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3031526-A1 Corrugated microporous tissue interface for improved performance and infection resistance of vascular grafts and other implantable devices Pending 26-Aug-2016 00000000
US-10751203-B2 Corrugated microporous tissue interface for improved performance and infection resistance of vascular grafts and other implantable devices Active 26-Aug-2016 00000000
US-20190358064-A1 Corrugated microporous tissue interface for improved performance and infection resistance of vascular grafts and other implantable devices Granted 26-Aug-2016 00000000
US-20180055668-A1 Corrugated microporous tissue interface for improved performance and infection resistance of vascular grafts and other implantable devices Granted 26-Aug-2016 00000000
US-10420659-B2 Corrugated microporous tissue interface for improved performance and infection resistance of vascular grafts and other implantable devices Active 26-Aug-2016 A61F2/91

Healionics Executive Team (3)

Name Title Board Seat Contact Info
Michael Connolly Chief Executive Officer & Chairman
Max Maginness Ph.D Co-Founder, President & Chief Operating Officer
Andrew Marshall Ph.D Board Member & Chief Technology Officer
To view Healionics’s complete executive team members history, request access »

Healionics Board Members (6)

Name Representing Role Since
Andrew Marshall Ph.D Healionics Board Member & Chief Technology Officer 000 0000
Arthur Coury Ph.D Self Board Member & Scientific Advisor 000 0000
Buddy Ratner Ph.D Self Scientific Advisor & Board Member 000 0000
Michael Connolly Healionics Chief Executive Officer & Chairman 000 0000
Ryan Takeuchi Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Healionics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Healionics Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arizona Tech Investors Angel Group Minority 000 0000 000000 0
Mid Atlantic Bio Angels Angel Group Minority 000 0000 000000 0
NO/LA Angel Network Angel Group Minority 000 0000 000000 0
Rockies Venture Club Angel Group Minority 000 0000 000000 0
Tech Coast Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Healionics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 14-Oct-2014 00000 0000 00.000 Surgical Devices 000 00000
To view Healionics’s complete investments history, request access »